{"protocolSection": {"identificationModule": {"nctId": "NCT00187200", "orgStudyIdInfo": {"id": "CRD299"}, "organization": {"fullName": "Abbott Medical Devices", "class": "INDUSTRY"}, "briefTitle": "Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients", "officialTitle": "RESPONSE HF - Response of Cardiac Resynchronization Therapy Optimization With Interventricular (VV) Timing in Heart Failure Patients"}, "statusModule": {"statusVerifiedDate": "2019-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2005-01"}, "primaryCompletionDateStruct": {"date": "2010-04", "type": "ACTUAL"}, "completionDateStruct": {"date": "2010-04", "type": "ACTUAL"}, "studyFirstSubmitDate": "2005-09-10", "studyFirstSubmitQcDate": "2005-09-10", "studyFirstPostDateStruct": {"date": "2005-09-16", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-08-27", "resultsFirstSubmitQcDate": "2015-08-25", "resultsFirstPostDateStruct": {"date": "2015-09-25", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2019-02-01", "lastUpdatePostDateStruct": {"date": "2019-02-05", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Abbott Medical Devices", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The purpose of the study is to evaluate the benefit of interventricular (V-V) delay optimization in reducing the non-responder rate in patients with cardiac resynchronization defibrillator (CRT-D) devices. The primary endpoint of this study is CRT responder rate.\n\nFor patients enrolled with new CRT-D systems, patients are considered non-responders if BOTH of the following requirements are fulfilled:\n\n* \\< 10% improvement in 6-minute hall walk, and\n* no class improvement or worsening in New York Heart Association (NYHA) scale.\n\nFor those receiving CRT-D devices as replacements of older CRT-D systems, patients are considered non-responders if BOTH of the following requirements are fulfilled:\n\n* \\> 1 heart failure (HF) related hospitalization, and\n* no class improvement or worsening in NYHA scale.", "detailedDescription": "Study Methods\n\n* This is a prospective, randomized (simultaneous biventricular (BiV) pacing vs. sequential BiV pacing) study.\n* Any patient that receives an FDA approved St. Jude Medical (SJM) CRT-D with V-V timing is eligible for enrollment.\n* At 3 months post enrollment (or at implant for CRT-D replacements), patients screened as non-responders are randomized to either simultaneous or sequential BiV pacing. Patients requiring a replacement CRT-D device that are identified as non-responders to CRT are enrolled at the screening/randomization visit.\n* Patients are followed for a period of 6 months post randomization:\n\n  * Enrollment (1 week pre CRT-D implant to \\< 2 weeks post CRT-D implant)\n  * Screening/Randomization Visit (3 months post enrollment)\n  * Follow-up Visit (6 months post randomization)\n* Total # of centers - 80 centers\n* Sample size - 800 patients screened for CRT non-responders"}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 816, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Simultaneous VV Pacing", "type": "ACTIVE_COMPARATOR", "description": "Programmed to simultaneous biventricular pacing", "interventionNames": ["Device: Simultaneous VV Pacing"]}, {"label": "Sequential VV Pacing", "type": "ACTIVE_COMPARATOR", "description": "Programmed to sequential biventricular pacing", "interventionNames": ["Device: Sequential VV Pacing"]}], "interventions": [{"type": "DEVICE", "name": "Simultaneous VV Pacing", "description": "Right ventricular and left ventricular pacing delivered simultaneously.", "armGroupLabels": ["Simultaneous VV Pacing"]}, {"type": "DEVICE", "name": "Sequential VV Pacing", "description": "Right ventricular and left ventricular pacing delivered sequentially.", "armGroupLabels": ["Sequential VV Pacing"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "CRT Responder Rate", "description": "Patients underwent baseline NYHA class and 6-minute hall walk distance (6-MHWD) assessment. After device implantation AV delays were optimized and all patients were programmed to simultaneous biventricular (BiV) pacing. At the 3-month follow-up, the NYHA class and 6-MHWD were reassessed. Non-responders were randomized 1:1 to either sequential BiV pacing with VV optimization or simultaneous BiV pacing. The responder rate at 6 months post randomization was compared between the two groups. Which is why the numbers are broken further down in the Outcome Measure table.", "timeFrame": "6 months"}], "secondaryOutcomes": [{"measure": "NYHA Class Progression", "description": "New York Heart Association (NYHA) functional classification provides a way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.", "timeFrame": "6 months"}, {"measure": "6 Minute Hall Walk Distance Test (6-MHWD)", "description": "Patients were considered non-responders if the 6-MHWD had not improved by greater than or equal to 10% compared to baseline. This statement is accurate and appropriate.", "timeFrame": "6 months"}, {"measure": "Left Ventricular Ejection Fraction (LVEF)", "description": "Ejection fraction is a measurement of the percentage of blood leaving your heart each time it contracts. The left ventricle is the heart's main pumping chamber, so ejection fraction is usually measured only in the left ventricle (LV).", "timeFrame": "Randomization and 9 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patient has a standard indication for a CRT-D.\n* Patient has the ability to complete a 6-minute hall walk with the only limiting factor to be fatigue or shortness of breath.\n* Patient is geographically stable and willing to comply with the required follow-up schedule.\n* Prior to 1 month of randomization, patient's HF medications are maintained stable and remain stable throughout the study.\n* Patients requiring a CRT-D replacement must comply with BOTH of the following:\n\n  * \\> 1 HF related hospitalization\n  * No class improvement or worsening in NYHA scale\n\nExclusion Criteria:\n\n* Patient's life expectancy is less than 12 months.\n* Patient has had cardiac surgery within 6 months of enrollment.\n* Patient has an epicardial ventricular lead system.\n* Patient is less than 18 years old.\n* Patient is pregnant.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Raul Weiss, MD", "affiliation": "Ohio State University", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Ohio State University", "city": "Columbus", "state": "Ohio", "zip": "43210", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "102 of the patients were non-responders, but only 93 were randomized of which 57 completed the study and had data available for analysis. of the 816 participants screened only 93 wre randomized to treatment. This statement is accurate and appropriate.", "recruitmentDetails": "816 patients were enrolled in the trial. Of the patients screened at the 3-month follow up, 572 patients were classified as responders and 102 patients as non-responders.", "groups": [{"id": "FG000", "title": "Simultaneous Pacing V-V Timing", "description": "Patients maintained on simultaneous V-V delay"}, {"id": "FG001", "title": "Sequential VV Pacing", "description": "V-V delay was optimized"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "49"}, {"groupId": "FG001", "numSubjects": "44"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "31"}, {"groupId": "FG001", "numSubjects": "26"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "18"}, {"groupId": "FG001", "numSubjects": "18"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Simultaneous Pacing V-V Timing", "description": "Patients maintained on simultaneous V-V delay"}, {"id": "BG001", "title": "Sequential VV Pacing", "description": "V-V delay was optimized"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "31"}, {"groupId": "BG001", "value": "26"}, {"groupId": "BG002", "value": "57"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "28"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "11"}, {"groupId": "BG002", "value": "29"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "68.2", "spread": "8.0"}, {"groupId": "BG001", "value": "62.4", "spread": "11.2"}, {"groupId": "BG002", "value": "65.6", "spread": "10.7"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "14"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "22"}, {"groupId": "BG001", "value": "21"}, {"groupId": "BG002", "value": "43"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "31"}, {"groupId": "BG001", "value": "26"}, {"groupId": "BG002", "value": "57"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "CRT Responder Rate", "description": "Patients underwent baseline NYHA class and 6-minute hall walk distance (6-MHWD) assessment. After device implantation AV delays were optimized and all patients were programmed to simultaneous biventricular (BiV) pacing. At the 3-month follow-up, the NYHA class and 6-MHWD were reassessed. Non-responders were randomized 1:1 to either sequential BiV pacing with VV optimization or simultaneous BiV pacing. The responder rate at 6 months post randomization was compared between the two groups. Which is why the numbers are broken further down in the Outcome Measure table.", "populationDescription": "Per protocol analysis.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "Simultaneous Pacing V-V Timing", "description": "Patients maintained on simultaneous V-V delay per protocol"}, {"id": "OG001", "title": "Sequential VV Pacing", "description": "V-V delay was optimized per protocol"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "26"}]}], "classes": [{"title": "Responders", "categories": [{"measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "20"}]}]}, {"title": "Non-Responders", "categories": [{"measurements": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "6"}]}]}]}, {"type": "SECONDARY", "title": "NYHA Class Progression", "description": "New York Heart Association (NYHA) functional classification provides a way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina pain.", "populationDescription": "Per protocol analysis", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "Simultaneous Pacing V-V Timing", "description": "Patients maintained on simultaneous V-V delay"}, {"id": "OG001", "title": "Sequential VV Pacing", "description": "V-V delay was optimized"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "26"}]}], "classes": [{"title": "NYYHA Class Improved by 1 category", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "17"}]}]}, {"title": "NYHA Class Improved by more than 1 category", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "NYHA Class Unchanged", "categories": [{"measurements": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "7"}]}]}, {"title": "NYHA Class Worsened", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}]}]}]}, {"type": "SECONDARY", "title": "6 Minute Hall Walk Distance Test (6-MHWD)", "description": "Patients were considered non-responders if the 6-MHWD had not improved by greater than or equal to 10% compared to baseline. This statement is accurate and appropriate.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "Simultaneous Pacing V-V Timing", "description": "Patients maintained on simultaneous V-V delay"}, {"id": "OG001", "title": "Sequential VV Pacing", "description": "V-V delay was optimized"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "26"}]}], "classes": [{"title": "Responder", "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "13"}]}]}, {"title": "Non-Responder", "categories": [{"measurements": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "13"}]}]}]}, {"type": "SECONDARY", "title": "Left Ventricular Ejection Fraction (LVEF)", "description": "Ejection fraction is a measurement of the percentage of blood leaving your heart each time it contracts. The left ventricle is the heart's main pumping chamber, so ejection fraction is usually measured only in the left ventricle (LV).", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage", "timeFrame": "Randomization and 9 months", "groups": [{"id": "OG000", "title": "Simultaneous Pacing V-V Timing", "description": "Patients maintained on simultaneous V-V delay"}, {"id": "OG001", "title": "Sequential VV Pacing", "description": "V-V delay was optimized"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "26"}]}], "classes": [{"title": "Randomization", "categories": [{"measurements": [{"groupId": "OG000", "value": "30.6", "spread": "10.5"}, {"groupId": "OG001", "value": "30.7", "spread": "10.5"}]}]}, {"title": "9 Month Follow-up Visit", "categories": [{"measurements": [{"groupId": "OG000", "value": "32.6", "spread": "11.8"}, {"groupId": "OG001", "value": "32.1", "spread": "11.6"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Simultaneous Pacing V-V Timing", "description": "Patients maintained on simultaneous V-V delay", "seriousNumAffected": 8, "seriousNumAtRisk": 31, "otherNumAffected": 7, "otherNumAtRisk": 31}, {"id": "EG001", "title": "Sequential VV Pacing", "description": "V-V delay was optimized", "seriousNumAffected": 2, "seriousNumAtRisk": 26, "otherNumAffected": 12, "otherNumAtRisk": 26}], "seriousEvents": [{"term": "ONSET OF ATRIAL FIBRILLATION", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "RV Lead Dislodgment or Migration", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "RV Elevated Pacing Thresholds", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "RV Decreased R/P-Wave Amplitude/Loss of Sensing", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "LEFT BRAIN TIA", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "LV Loss of capture", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "BACTEREMIA", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "Therapy/Aborted Therapy for Non-Ventricular Rhythm:AF/AFL", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "MULTIPLE ICD FIRING, NSTEMI", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "CHEST PAIN AND AICD FIRING", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}], "otherEvents": [{"term": "DIAPHRAGMATIC CAPTURE BY ATRIAL LEAD", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "CHF EXACERBATION", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "CHF EXACERBATION + NEAR SYNCOPE", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "SHORTNESS OF BREATH", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "NEAR SYNCOPE WITH GENERAL WEAKNESS", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "HOSPITALIZATION FOR WEAKNESS WITH ICD FIRING X 2", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "PNEUMONIA AND WORSENING KIDNEY FUNCTION", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "END STAGE RENAL DZ - (WORSENING OF KNOWN DISEASE)", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "MRSA INFECTED LEFT ARM DIALYSIS GRAFT", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "HOSPITALIZATION FOR NEAR SYNCOPE", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "DIZZY SPELL", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "ANEMIA", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "ACUTE VIRAL PERICARDITIS", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "ABDOMINAL AORTIC ANEURYSM", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "SYNCOPE", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "SINUS INFECTION", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "COPD (CHRONIC)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 26}]}, {"term": "EXACERBATION CONGESTIVE HEART FAILURE", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}, {"term": "WORSENING RENAL FUNCTION", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 26}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "Due to the lower than expected non-responder rate at 3 months, the study did not reach the target randomized sample size."}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Publications and presentation should be presented to sponsor 30 days (manuscripts) or 7 days (abstracts) prior to submission for publication. The sponsor reserves the right to deny submission of study results if based on data owned by sponsor."}, "pointOfContact": {"title": "Ashish Oza", "organization": "St. Jude Medical", "email": "aoza@sjm.com", "phone": "(818) 493-3648"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}